Skip to Main content Skip to Navigation
Journal articles

Interaction of recombinant octameric hemoglobin with endothelial cells

Abstract : Hemoglobin-based oxygen carriers (HBOCs) may generate oxidative stress, vasoconstriction and inflammation. To reduce these undesirable vasoactive properties, we increased hemoglobin (Hb) molecular size by genetic engineering with octameric Hb, recombinant (r) HbβG83C. We investigate the potential side effects of rHbβG83C on endothelial cells. The rHbβG83C has no impact on cell viability, and induces a huge repression of endothelial nitric oxide synthase gene transcription, a marker of vasomotion. No induction of Intermolecular-Adhesion Molecule 1 and E-selectin (inflammatory markers) transcription was seen. In the presence of rHbβG83C, the transcription of heme oxygenase-1 (oxidative stress marker) is weakly increased compared to the two other HBOCs (references) or Voluven (control). This genetically engineered octameric Hb, based on a human Hb βG83C mutant, leads to little impact at the level of endothelial cell inflammatory response and thus appears as an interesting molecule for HBOC development.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-lorraine.fr/hal-01291903
Contributor : Cithefor Ul <>
Submitted on : Tuesday, March 22, 2016 - 11:58:12 AM
Last modification on : Friday, September 10, 2021 - 1:04:03 PM

Identifiers

Citation

Caroline Gaucher, Élisa Domingues-Hamdi, Christine Prin-Mathieu, Patrick Menu, Véronique Baudin-Creuza. Interaction of recombinant octameric hemoglobin with endothelial cells. Comptes Rendus Biologies, Elsevier Masson, 2015, 338 (2), pp.95-102. ⟨10.1016/j.crvi.2014.11.004⟩. ⟨hal-01291903⟩

Share

Metrics

Record views

179